Clinical Trial Update: Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy of pantoprazole for gastroesophageal reflux symptoms in adults 18 and older; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoprazole (pantoprazole)

Snippet

Sponsor: Takeda | Conditions: Gastroesophageal Reflux | Phase 3 | Status: COMPLETED